Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emla cream versus lidocaine infiltration for first-degree perineal tear repair
2024-512728-12-00Phase 4Authorised
- Sponsor
- Foundation for the Incentive of Research
- Start
- Jul 2024
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial in perineal laceration comparing Topical EMLA cream with Injectable lidocaine 2% (2 arms). Primary endpoint: Pain intensity during and after repair measured with modified Visual Analogue Scale (VAS). Planned start Jul 2024; status: authorised.
02
Drugs
lidocaine + prilocainelidocaine
03
Conditions
perineal laceration
Beyond the preview
Go deeper on 2024-512728-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512728-12-00.